Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Age-related sensitivity to remimazolam and ciprofol for procedural sedation during induction of general anesthesia
ChiCTR2300068310Phase 4Not yet recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Feb 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and ciprofol (4 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoints: Observer's assessment of alertness/sedation (OAA/S) scale and Bispectral index (BIS). Planned start Feb 2023; status: not yet recruiting.
02
Drugs
remimazolamciprofol
Beyond the preview
Go deeper on ChiCTR2300068310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068310.